donafenib: Clinical Trials

3 trials of donafenib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Not yet recruiting 2, Unknown 1

Follow donafenib: new trials by email Literature Review of donafenib trials Research Report on donafenib

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
HAIC, Donafenib + lenvatinib+apatinib, Sintilimab+camrelizumab+tislelizumab - Liver Cancer
Phase 4Not yet recruitingZhai Wenlong402026-08-302026-08-27
Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous Therapy
Donafenib, transhepatic arterial embolization chemotherapy or hepatic arterial infusion chemotherapy, PD-1,PD-L1 - Unresectable Hepatocellular Carcinoma
Phase 4Not yet recruitingTongji Hospital322024-08-012024-07-11
Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis
Donafenib - HCC, Chemotherapy Effect
Phase 4UnknownAnhui Provincial Hospital302021-09-302021-09-21

Conditions studied

Liver Neoplasms (1)

Sponsors

Anhui Provincial Hospital (1)  ·  Tongji Hospital (1)  ·  Zhai Wenlong (1)

Countries

China (1)

Top investigators

Zhiyong Huang (1)